The Return on Investment with Stradasys AES ranges from 5 to 10 percent of your revenue.

The Investment
Stradasys AES assists physicians in gaining substantial revenue enhancement with minimal resource investment. Maximum financial impact is achieved through multiple methodologies to give you a significant return on investment. The Stradasys ROI is realized by:
»  Producing a variety of Stradasys AES analyses that can add “real dollars” to your bottom line by identifying both operational and payor performance revenue improvement opportunities.
»  Requiring minimal critical resource consumption - time, effort, and staff – to achieve significant results via its comprehensive, yet simple and easy-to-understand analyses.
»  Offering a unique pay-per-use pricing structure that responds to each provider’s budgetary requirements, achieving maximum impact with minimal upfront investment.

Stradasys AES Achieves Tangible ROI Throughout Its Use.
Short Term ROI – Charge Master Review
Stradasys AES discovers immediate sources of revenue by analyzing your charge master. Most practices utilize a CPT code based fee structure that results in receipts less than what payors would reimburse. Stradasys’ analyses quickly identify these situations and indicate alternative fees options so you no longer leave money on the table. Clients have discovered several thousands of dollars lost every year through under-billed claims.

Intermediate Term ROI – Contract Compliance
Stradasys AES detects third party claim payments that deviate from agreed-upon reimbursement fee schedules and payment rules. It equips office staff with tools and information necessary to identify and track the most problematic payors and claim situations that aids in recouping unpaid dollars. While attaining full momentum for recoupment through an appeals process may require 3-6 months, exposure of underpayments is ongoing. The industry standard of under-reimbursements ranges between 5% and 20% of net receipts.

Long Term ROI – Payor and Profit Performance
Stradasys AES analyzes the revenue performance of payors in a multitude of ways – in aggregate; by plan, payor and product; or by physician, location, and practice group for an unlimited timeframe in order to enable enhanced strategic planning and contract modeling. The analyses will empower your payor contract negotiations and business decisions. Furthermore, it can analyze the profitability of ancillary procedures, lab tests and capital investments. Understanding and managing the financial performance of your payors and operations will improve your bottom line.

Would you like to learn more about AES? Call us today to schedule a product demonstration.